One River Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87K Sell
3,100
-118,100
-97% -$3.14M 0.03% 229
2025
Q4
$3.02M Buy
121,200
+60,600
+100% +$1.53M 0.29% 50
2025
Q3
$1.54M Buy
60,600
+59,994
+9,900% +$1.48M 0.42% 56
2025
Q2
$162K Sell
606
-59,994
-99% -$1.4M 0.36% 33
2025
Q1
$1.54M Buy
+60,600
New +$1.59M 0.24% 55

Other funds holding PFE

One River Asset Management's PFE Position: Q1 2026 in Review

One River Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 24,450 shares — an estimated $651K sold.

One River Asset Management first reported a position in PFE in Q1 2025 and held it in 4 quarters. The position peaked at $609K in Q4 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • One River Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • One River Asset Management sold 24,450 Pfizer shares in Q1 2026, an estimated $651K.
  • One River Asset Management first reported a position in Pfizer in Q1 2025 and held it in 4 quarters.
  • One River Asset Management's Pfizer position peaked at $609K in Q4 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on One River Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.